Drug Shortage Report for EPHEDRINE SULFATE INJECTION USP
Report ID | 1218 |
Drug Identification Number | 00038121 |
Brand name | EPHEDRINE SULFATE INJECTION |
Common or Proper name | Ephedrine |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | EPHEDRINE SULFATE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | 50mg/1mL x 50 |
ATC code | R03CA |
ATC description | ADRENERGICS FOR SYSTEMIC USE |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2015-07-24 |
Estimated end date | |
Actual end date | 2019-03-29 |
Shortage status | Resolved |
Updated date | 2019-03-30 |
Company comments | Product is discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-13 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v3 | 2017-03-14 | English | Compare |
v4 | 2017-03-14 | French | Compare |
v5 | 2019-03-29 | English | Compare |
v6 | 2019-03-29 | French | Compare |
v7 | 2019-03-30 | English | Compare |
Showing 1 to 7 of 7